Paraneoplastic syndromes related to lung cancer

Clinical Journal of Oncology Nursing

Volumn 14, Issue 3, 2010, Pages 357-364

  McClelland, Mary T ^a  

^a Queens Medical Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; LUNG TUMOR; PARANEOPLASTIC SYNDROME; REVIEW;

HUMANS; LUNG NEOPLASMS; PARANEOPLASTIC SYNDROMES;

EID: 77956193424     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/10.CJON.357-364     Document Type: Article

References (34)

1. Agraharkar, M. (2009). Hypercalcemia. Retrieved from http://emedicine.medscape.com/article/240681-overview
2. Armstrong, T.S. (2005). Paraneoplastic syndromes. In C.H. Yarbro, M.H. Frogge, & M. Goodman (Eds.), Cancer nursing: Principles and practice (6th ed., pp. 808-824). Sudbury, MA: Jones and Bartlett.
3. Body, J.J. (2004). Hypercalcemia of malignancy. Seminars in Nephrology, 24, 48-54.
4. Callen, J.P., & Wortmann, R.L. (2006). Dermatomyositis. Clinics in Dermatology, 24, 363-373. doi: 10.1016/j.clindermatol.2006.07.001
5. Collins, L.G., Haines, C., Perkel, R., & Enck, R.E. (2007). Lung cancer: Diagnosis and management. American Family Physician, 75, 56-63.
6. Dalmau, J. (2007). Paraneoplastic disorders of the nervous system. European Journal of Cancer Supplements, 5, 53-67.
7. Darnell, R.B., & Posner, J.B. (2006). Paraneoplastic syndromes affecting the nervous system. Seminars in Oncology, 33, 270-298. doi: 10.1053/j.seminoncol.2006.03.008
8. de Beukelaar, J.W., & Sillevis Smitt, P.A. (2006). Managing paraneoplastic neurological disorders. Oncologist, 11, 292-305. doi: 10.1634/theoncologist.11-3-292
9. Dolbey, C.H. (2003). Hypercalcemia of malignancy. In M.E. Wood, & G.K. Philips (Eds.), Hematology/oncology secrets (3rd ed., pp. 238-243). Philadelphia, PA: Hanley and Belfus.
10. Ghfir, I., & Rais, N.B. (2007). Primary lung cancer revealed by dermatomyositis and detected by whole-body scintigraphy with 99mTc-HMDP. Internet Journal of Nuclear Medicine, 3(2), 5. Retrieved from http://www.ispub.com/ostia/index.php?xmlFilePath=journals/ijnuc/vol3n2/dm.xml
11. Hempill, R.R. (2007). Hypercalcemia. Retrieved from http://www.emedicine.com/emerg/topic260.htm
12. Honnorat, J. (2006). Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes. Acta Neurologica Scandinavica. Supplementum, 113(Suppl. 183), 64-68. doi: 10.1111/j.1600-0404.2006.00620.x
13. Honnorat, J., & Antoine, J.C. (2007). Paraneoplastic neurological syndromes. Orphanet Journal of Rare Diseases, 2, 1-8. doi: 10.1186/1750-1172-2-22
14. Jameson, J.L., & Johnson, B.E. (2008). Paraneoplastic syndromes: Endrocrinologic/hematologic. In A.S. Fauci, E. Braunwald, D.L. Kasper, S.L. Hauser, D.L. Longo, J.L Jameson, & J. Loscalzo (Eds.), Harrison's principles of internal medicine (17th ed., pp. 808-824). Sudbury, MA: Jones and Bartlett.
15. Kaplan, M. (2006). Hypercalcemia of malignancy. In M. Kaplan (Ed.), Understanding and managing oncologic emergencies: A resource for nurses (pp. 51-97). Pittsburgh, PA: Oncology Nursing Society.
16. Knop, C.S. (2005). Lung cancer. In C.H. Yarbro, M.H. Frogge, & M. Goodman (Eds.), Cancer nursing: Principles and practice (6th ed., pp. 1379-1413). Sudbury, MA: Jones and Bartlett.
17. Li-Ng, M., & Verbalis, J.G. (2009). Conivaptan: Evidence supporting its therapeutic use in hyponatremia. Core Evidence, 4, 83-92. Retrieved from http://www.dovepress.com/conivaptan-evidence-supporting-its-therapeutic-use-in-hyponatremia-peer-reviewed-article-CE
18. Maghfoor, I., & Perry, M. (2005). Lung cancer, non-small cell. Retrieved from http://www.emedicine.com/med/topic1333.htm
19. Mazzone, P.J., & Arroliga, A.C. (2003). Endocrine paraneoplastic syndromes in lung cancer. Current Opinion in Pulmonary Medicine, 9, 313-320.
20. McDonnell Keenan, A.M.K., & Wickham, R.S. (2005). Hypercalcemia. In C.H. Yarbro, M.H. Frogge, & M. Goodman (Eds.), Cancer nursing: Principles and practice (6th ed., pp. 791-807). Sudbury, MA: Jones and Bartlett.
21. Newell-Price, J., Bertagna, X., Grossman, A.B., & Nieman, L.K. (2006). Cushing's syndrome. Lancet, 367, 1605-1617. doi: 10.1016/S0140-6736(06)68699-6
22. Onitilo, A.A., Kio, E., & Doi, S.A. (2007). Tumor-related hyponatremia. Clinical Medicine and Research, 5, 228-237. doi: 10.3121/cmr.2007.762
23. Potts, J.T., Jr. (2005). Diseases of the parathyroid gland and other hyper- and hypocalcemic disorders. In D.L. Kasper, E. Braunwald, A.S. Fauci, S.L. Hauser, D.L. Longo, & J.L. Jameson (Eds.), Harrison's principles of internal medicine (16th ed., pp. 2249-2268). Sudbury, MA: Jones and Bartlett.
24. Raza, A.M., & Tandan, R. (2003). Paraneoplastic neurologic syndromes. In M.E. Wood & G.K. Philips (Eds.), Hematology/oncology secrets (3rd ed., pp. 243-250). Philadelphia, PA: Hanley and Belfus.
25. Richerson, M.T. (2004). Electrolyte imbalances. In C.H. Yarbro, M.H. Frogge, & M. Goodman (Eds.), Cancer symptom management (3rd ed., pp. 440-460). Sudbury, MA: Jones and Bartlett.
26. Ruddy, K.J., & Hochberg, F.H. (2008). In B.A. Chabner, T.J. Lynch, & D.L. Longo (Eds.), Harrison's manual of oncology. New York, NY: McGraw-Hill.
27. Rudnicki, S.A., & Dalmau, J. (2005). Paraneoplastic syndromes of the peripheral nerves. Current Opinion in Neurology, 18, 598-603.
28. Rugo, H.S. (2007). Oncology. In S.J. McPhee, M.A. Papadakis, & L.M. Tierney (Eds.), Current medical diagnosis and treatment 2008 (47th ed., pp. 808-824). Sudbury, MA: Jones and Bartlett.
29. Santacroce, L., & Gagliardi, S. (2005). Paraneoplastic syndromes. Retrieved from http://www.emedicine.com/MED/topic1747.htm
30. Spiro, S.G., Gould, M.K., & Colice, G.L. (2007). Initial evaluation of the patient with lung cancer: Symptoms, signs, laboratory tests, and paraneoplastic syndrome: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest, 132(3, Suppl.), 149S-160S. Retrieved from http://chestjournal.chestpubs.org/content/132/3_suppl/149S.long
31. Stewart, A.F. (2005). Hypercalcemia associated with cancer. New England Journal of Medicine, 352, 373-379. doi: 10.1056/NEJMcp042806
32. Thomas, L., Kwok, Y., & Edelman, M.J. (2004). Management of paraneoplastic syndromes in lung cancer. Current Treatment Options in Oncology, 5, 51-62.
33. Turker, H., Unsal, M., & Onar, M. (2007). Peripheral and central nervous system involvement in lung cancer. Turkish Journal of Cancer, 37, 5-10.
34. Vedeler, C.A., Antoine, J.C., Giometto, B., Graus, F., Grisold, W., Hart, I.K., Voltz, R. (2006). Management of paraneoplastic neurological syndromes: Report of an EFNS task force. European Journal of Neurology, 13, 682-690. doi: 10.1111/j.1468-1331.2006.01266.x